Business Description
CareDx Inc
NAICS : 325413
SIC : 8071
ISIN : US14167L1035
Share Class Description:
CDNA: Ordinary SharesDescription
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.88 | |||||
| Equity-to-Asset | 0.56 | |||||
| Debt-to-Equity | 0.13 | |||||
| Debt-to-EBITDA | -0.4 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -0.92 | |||||
| Beneish M-Score | -3.45 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8 | |||||
| 3-Year EBITDA Growth Rate | -107.8 | |||||
| 3-Year EPS without NRI Growth Rate | -78.1 | |||||
| 3-Year Book Growth Rate | -3.3 | |||||
| Future 3-5Y Total Revenue Growth Rate | -0.77 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.9 | |||||
| 9-Day RSI | 32.98 | |||||
| 14-Day RSI | 36.41 | |||||
| 6-1 Month Momentum % | 75.43 | |||||
| 12-1 Month Momentum % | 8.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.02 | |||||
| Quick Ratio | 3.77 | |||||
| Cash Ratio | 3.02 | |||||
| Days Inventory | 66.95 | |||||
| Days Sales Outstanding | 72.92 | |||||
| Days Payable | 39.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.4 | |||||
| Shareholder Yield % | 4.95 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 63.61 | |||||
| Operating Margin % | -37.37 | |||||
| Net Margin % | -67.88 | |||||
| FCF Margin % | -9.86 | |||||
| ROE % | -49.77 | |||||
| ROA % | -37.25 | |||||
| ROIC % | -53.83 | |||||
| ROC (Joel Greenblatt) % | -128.21 | |||||
| ROCE % | -24.01 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.58 | |||||
| PB Ratio | 1.66 | |||||
| Price-to-Tangible-Book | 2.48 | |||||
| EV-to-EBIT | -2.18 | |||||
| EV-to-EBITDA | -2.69 | |||||
| EV-to-Revenue | 0.81 | |||||
| EV-to-Forward-Revenue | 0.86 | |||||
| EV-to-FCF | -8.24 | |||||
| Price-to-Net-Current-Asset-Value | 4 | |||||
| Price-to-Net-Cash | 14.48 | |||||
| Earnings Yield (Greenblatt) % | -45.87 | |||||
| FCF Yield % | -6.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CDNA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CareDx Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 280.324 | ||
| EPS (TTM) ($) | -3.53 | ||
| Beta | 2.17 | ||
| Volatility % | 106.17 | ||
| 14-Day RSI | 36.41 | ||
| 14-Day ATR ($) | 0.606572 | ||
| 20-Day SMA ($) | 9.518 | ||
| 12-1 Month Momentum % | 8.33 | ||
| 52-Week Range ($) | 4.8 - 12.93 | ||
| Shares Outstanding (Mil) | 51.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CareDx Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CareDx Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
CareDx Inc Frequently Asked Questions
What is CareDx Inc(CDNA)'s stock price today?
The current price of CDNA is $8.41. The 52 week high of CDNA is $12.93 and 52 week low is $4.80.
When is next earnings date of CareDx Inc(CDNA)?
The next earnings date of CareDx Inc(CDNA) is 2024-05-10 Est..
Does CareDx Inc(CDNA) pay dividends? If so, how much?
CareDx Inc(CDNA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers